This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Asia-Pacific

  1. With a recent approval from the World Health Organization, this high-quality, more affordable vaccine is poised to help more countries access protection against the top cause of deadly childhood pneumonia.
    Published: December 2019
    Type: Article
  2. This fact sheet provides an overview of pneumonia and other pneumococcal diseases, including disease burden and prevention and treatment measures. It also summarizes the pneumococcal conjugate vaccine (PCV) landscape, including the addition of Serum Institute of India, Pvt., Ltd.'s PCV (PNEUMOSIL®) to the suite of World Health Organization (WHO) prequalified PCVs. Also described are the Phase 3 clinical study results that constituted the pivotal data required for WHO prequalification.
    Published: December 2019
    Type: Resource Page
  3. This milestone marks a key step toward improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low- and middle-income countries
    Published: December 2019
    Type: Press Release
  4. Following a highly successful vaccination campaign, Sindh Province turns to routine immunization.
    Published: December 2019
    Type: Article
  5. A massive typhoid vaccination campaign is underway, using a new vaccine to protect kids.
    Published: December 2019
    Type: Article
  6. Published: November 2019
    Type: Press Release
  7. India continues to be one of the most populous countries on the planet and, consequently, faces immense health challenges due to its growing population. Since 1978, PATH has been working with public and private partners in India to develop local solutions, support homegrown innovation, and share our technical expertise. PATH develops, introduces, and scales up cutting-edge technologies and methodologies to tackle existing diseases and emerging health concerns. A few of our many successes in India include finding new methods to deliver nutritious food to schoolchildren, creating and implementing successful public-private partnership models to combat diseases, and expanding access to lifesaving vaccines for new mothers and their infants.
    Published: November 2019
    Type: Resource Page
  8. A multi-pronged approach is trying to combat hidden hunger and reduce micronutrient malnutrition in millions of Indians.
    Published: October 2019
    Type: Article
  9. The STANDARD™ G6PD has achieved provisional Expert Review Panel for Diagnostics (ERPD) approval, which enables procurement with Global Fund and Unitaid funds. Point-of-care diagnostics for G6PD deficiency play a critical role in supporting appropriate treatment of Plasmodium vivax malaria and efforts to eliminate the disease.
    Published: October 2019
    Type: Article
  10. A story of loss, love, and new hope—in the form of a vaccine.
    Published: October 2019
    Type: Article
Load more